Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jie-xuan Hu"'
Autor:
Ru-Yue Tian, Qiang Su, Wei Wang, Yan-li Hou, Hongyang Li, Diya Wang, Yanling Wang, Jie-xuan Hu
Background We performed a systematic review and meta-analysis to evaluate the risks of ophthalmic adverse events (AEs) associated with immune checkpoint inhibitors (ICIs) in patients with solid tumors.Methods Eligible studies were selected after a co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e93b3fdf4aace9b7222f324edf5363bf
Autor:
Qiang Su, Chen-guang Zhang, Zheng Zhang, Hai-shan Lin, Emily C Zhu, Jie-xuan Hu, Bangwei Cao, Zu-Hua Gao, Di-ya Wang
SummaryBackgroundThe corona virus disease 2019 (COVID-19) pandemic poses a severe challenge to public health, especially to those patients with underlying diseases. In this meta-analysis, we studied the prevalence of cancer among patients with COVID-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44edb31dbb0fafb4b5a7cf25cb3de8c2
Publikováno v:
European Journal of Clinical Pharmacology
Background This meta-analysis examined the risk of hepatotoxicity in patients with solid tumors who received a PD-1/PD-L1 inhibitor alone, a PD-1/PD-L1 inhibitor plus chemotherapy, or chemotherapy alone. Methods Potentially eligible studies were iden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3aa73a45c9159e79c5eae898ccddf8b
https://pubmed.ncbi.nlm.nih.gov/32507925
https://pubmed.ncbi.nlm.nih.gov/32507925
Autor:
Hou, Yan-Li1 (AUTHOR), Wang, Di-Ya2 (AUTHOR), Hu, Jie-Xuan3 (AUTHOR), Tian, Ru-Yue3 (AUTHOR), Wang, Wei3 (AUTHOR), Su, Qiang3 (AUTHOR) qiang.su@ccmu.edu.cn, Li, Hongyang1,4 (AUTHOR) faraway_sweet@163.com, Wang, Yan-Ling1 (AUTHOR)
Publikováno v:
Ocular Immunology & Inflammation. Aug2022, Vol. 30 Issue 6, p1449-1459. 11p.